Open AccessGrazoprevir/Elbasvir Treatment in Liver or Kidney Transplant Recipients with Genotype 1b Hepatitis C Virus Infection
Author(s) -
PingChin Lai,
ChengHsu Chen,
LongBin Jeng,
TungMin Yu,
ShangFeng Tsai,
MingJu Wu,
ShaoBin Cheng,
ShengShun Yang,
TengYu Lee
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02003-21
Subject(s) - medicine , tolerability , regimen , adverse effect , hepatitis c , gastroenterology , ribavirin , hepatitis c virus , immunology , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom